Ben Hurlbut

Ben Hurlbut, a bioethicist and associate professor, dives deep into the ethical implications of CRISPR in this engaging conversation. He discusses the balance between innovation and ethics, especially after the controversial actions of He Jiankui. Hurlbut emphasizes the importance of public dialogue around genetic editing, urging society to consider the 'shoulds' before the 'cans.' The discussion also touches on the equity of access to new therapies and the necessity for ongoing ethical considerations in the biotechnology landscape.